secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verrica Pharmaceuticals Inc. (VRCA)
CIK:        0001660334
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001193125-25-096909
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verrica Pharmaceuticals' Chief Legal Officer Christopher Hayes resigns effective April 30, 2025
--------------------------------------------------------------------------------

- Christopher G. Hayes resigns as Chief Legal Officer, Chief Compliance Officer, and Corporate Secretary effective April 30, 2025.
- Company enters Release Agreement providing 12 months of base salary continuation and up to 12 months of COBRA coverage.
- No permanent replacement has been announced for Hayes' roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525096909/0001193125-25-096909-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1660334/000119312525096909/d807929d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-096909

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer